Strs Ohio Cuts Holdings in HCA Healthcare, Inc. $HCA

Strs Ohio lowered its holdings in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 5.9% in the 1st quarter, Holdings Channel reports. The firm owned 81,587 shares of the company’s stock after selling 5,140 shares during the period. Strs Ohio’s holdings in HCA Healthcare were worth $38,610,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. James Investment Research Inc. grew its stake in shares of HCA Healthcare by 39.3% in the first quarter. James Investment Research Inc. now owns 4,444 shares of the company’s stock worth $2,103,000 after acquiring an additional 1,254 shares during the period. Vertrix Wealth Management LLC purchased a new stake in HCA Healthcare in the first quarter worth approximately $269,000. USS Investment Management Ltd raised its stake in HCA Healthcare by 1.8% during the 1st quarter. USS Investment Management Ltd now owns 29,052 shares of the company’s stock valued at $13,740,000 after buying an additional 521 shares during the last quarter. MQS Management LLC boosted its stake in shares of HCA Healthcare by 48.3% in the 1st quarter. MQS Management LLC now owns 1,530 shares of the company’s stock worth $724,000 after buying an additional 498 shares during the last quarter. Finally, Premier Path Wealth Partners LLC increased its position in HCA Healthcare by 17.8% during the first quarter. Premier Path Wealth Partners LLC now owns 2,302 shares of the company’s stock valued at $1,089,000 after acquiring an additional 348 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Down 0.1%

NYSE:HCA opened at $409.99 on Friday. The company has a market capitalization of $90.95 billion, a P/E ratio of 14.10, a P/E/G ratio of 1.30 and a beta of 1.12. The business’s 50-day moving average is $400.65 and its 200 day moving average is $462.43. HCA Healthcare, Inc. has a 12 month low of $330.00 and a 12 month high of $556.52.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm had revenue of $19.11 billion for the quarter, compared to analysts’ expectations of $19.09 billion. During the same period last year, the company earned $6.45 earnings per share. The firm’s revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, research analysts forecast that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th were issued a $0.78 dividend. The ex-dividend date was Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s payout ratio is 10.73%.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on HCA shares. Wells Fargo & Company cut their price target on HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating for the company in a research note on Monday, April 27th. Barclays cut their target price on shares of HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. KeyCorp dropped their price target on shares of HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Royal Bank Of Canada reduced their price objective on HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating for the company in a research note on Monday, April 27th. Finally, Jefferies Financial Group reissued a “buy” rating and set a $525.00 price target on shares of HCA Healthcare in a report on Friday, April 24th. Fifteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $503.00.

View Our Latest Stock Analysis on HCA

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Featured Articles

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.